Composition
- Active ingredients
- ASPIRIN 385MG; CAFFEINE 30MG; ORPHENADRINE CITRATE 25MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA074817.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Invagesic
- Active substance
- aspirin
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Chartwell RX
- Status
- Discontinued
- FDA approval
- 27 Nov 1996
- Application
- ANDA074817-001